Inspection Record

East Orange VA Medical Center — FDA 483 Findings

US FDAInspected 2025-04-29Published 2025-06-02 3 findingsEquipment and facilityOther quality systemContamination control

Inspectors Logan T WilliamsThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Equipment and facility

Production areas have difficult to clean or contain porous, particle generating, or visibly duty equipment or surfaces.

2Other quality system

The sinks are present directly adjacent to the ISO 5 area.

3Contamination control

Beta-lactam drugs were produced without providing adequate containment, segregation, and/or cleaning of work surfaces, utensils, and/or personnel to prevent cross-contamination.

About this record

Extracted automatically from the document US FDA published on 2025-06-02. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

East Orange VA Medical Center company profile — full history US FDA documents, 2025 Go to Findings search